Anne F. Schott

ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome

Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe‐Jauffret et al. · Cell stem cell · 2007 · 4K citations · Full text

Lineage Plasticity, Breast Oncology, Medicine +9

Activating ESR1 mutations in hormone-resistant metastatic breast cancer

Dan R. Robinson, Yi-Mi Wu, Pankaj Vats et al. · Nature Genetics · 2013 · 1.1K citations · Full text

Breast Oncology, Medicine, Breast Cancer +6

Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps

Juwon Park, Robert W. Wysocki, Zohreh Amoozgar et al. · Science Translational Medicine · 2016 · 953 citations · Full text

Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500

Jeffrey B. Smerage, William E. Barlow, Gabriel N. Hortobágyi et al. · Journal of Clinical Oncology · 2014 · 629 citations · Full text

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7